Back
Krystal Biotech Inc (KRYS)
BiotechnologyKRYS · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$368.60
−1.62%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$6.84
ROE
19.9%
Gross margin
94.2%
Debt/Equity
0.71x
Revenue growth
31.9%
Krystal Biotech Inc — company intelligence
Earnings surprises
Q1 2026$1.83 vs $1.45 est+26.3%
Q4 2025$1.70 vs $1.44 est+18.3%
Q3 2025$2.66 vs $1.11 est+140.2%
Q2 2025$1.29 vs $1.15 est+12.1%
Analyst consensus · 18 analysts
16 Buy2 Hold0 Sell
Updated Jul 7, 2026
Insider activity · 90 days
0 buys23 sellsnet -50,642 shares
Thomas John Charlesother 1,000 · Jun 25, 2026
Krishnan Krish SSell 176 · Jun 4, 2026
Krishnan Krish SSell 320 · Jun 4, 2026
Recent SEC filings
4 — Insider transaction reportJun 26, 2026
4 — Insider transaction reportJun 5, 2026
4 — Insider transaction reportJun 5, 2026
Latest news
TD Cowen Maintains Buy on Krystal Biotech, Raises Price Target to $403 — Benzinga · 3w ago
HC Wainwright & Co. Maintains Buy on Krystal Biotech, Raises Price Target to $361 — Benzinga · 3w ago
Exploring 3 High Growth Tech Stocks In The US Market — Yahoo · Jun 5, 2026
Is the Options Market Predicting a Spike in Krystal Biotech Stock? — Yahoo · Jun 5, 2026
Why Is Techne (TECH) Up 4.5% Since Last Earnings Report? — Yahoo · Jun 5, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Krystal Biotech Inc
Weekly undervalued picks (like KRYS)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.